| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/08/2006 | WO2005100985A3 Multiple sorter monitor and control subsystem for flow cytometer |
| 09/08/2006 | WO2005091805A3 Methods and compositions for inhibition of metastasis |
| 09/08/2006 | WO2005059515A3 Method for treating neurological disorders |
| 09/08/2006 | WO2005050167A3 Rapid sample collection and analysis device |
| 09/08/2006 | WO2005025517A3 Animal model for protease activity and liver damage |
| 09/08/2006 | WO2005010035A3 Alternate reading frame polypeptides derived from hepatitis c and methods of their use |
| 09/08/2006 | WO2005003307A3 Compositions and methods for analysis and manipulation of enzymes in biosynthetic proteomes |
| 09/08/2006 | WO2004081531A3 Ligand analysis |
| 09/08/2006 | WO2004081528A3 Assay device and method |
| 09/08/2006 | WO2004075724A3 Serotonin and catecholamine system segment optimization technology |
| 09/08/2006 | WO2004053106A3 Profiled regulatory sites useful for gene control |
| 09/08/2006 | WO2004053066A3 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 09/08/2006 | WO2004029071A3 Mage-c2 antigenic peptides and uses thereof |
| 09/08/2006 | WO2004028346A3 Detection methods |
| 09/08/2006 | WO2004000101A3 Method for predicting response to her1/her2-directed therapy |
| 09/08/2006 | WO2003062385A3 Secretory molecules |
| 09/08/2006 | CA2833783A1 Design and synthesis of novel antimicrobials |
| 09/08/2006 | CA2603677A1 Methyltransferases and their uses |
| 09/08/2006 | CA2600911A1 Immunoassay with extended dynamic range |
| 09/08/2006 | CA2600592A1 Biosensor unified with needle |
| 09/08/2006 | CA2600154A1 Fluorescence polarization assays for acetyltransferase/deacetylase activity |
| 09/08/2006 | CA2599975A1 Surfaces coated with target-induced fluorescent compounds for detection of target elements |
| 09/08/2006 | CA2599743A1 A method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom |
| 09/08/2006 | CA2599740A1 A method for identifying skin care composition-resistant skin-binding peptides |
| 09/08/2006 | CA2599731A1 Quantification of proteins |
| 09/08/2006 | CA2599669A1 Assay method for human orotate phosphoribosyltransferase protein |
| 09/08/2006 | CA2599520A1 Radioisotope labelled biological compositions, and their use in accelerator mass spectrometry |
| 09/08/2006 | CA2599364A1 Fluorous-based microarrays |
| 09/08/2006 | CA2599197A1 Chemiluminescent method and device for evaluating the in vivo functional state of phagocytes |
| 09/08/2006 | CA2597862A1 Use of thiopeptolides for determining the activity of adamts proteases |
| 09/08/2006 | CA2597671A1 Method and device for bacterial sampling |
| 09/08/2006 | CA2586208A1 Human obesity susceptibility gene encoding potassium ion channels and uses thereof |
| 09/08/2006 | CA2583304A1 Pharmacodynamic marker for histone deacetylase inhibitor |
| 09/08/2006 | CA2575611A1 Covalent tethering of functional groups to proteins and substrates therefor |
| 09/08/2006 | CA2573392A1 Methods of detecting a phenotype of a polymorphic protein |
| 09/08/2006 | CA2571400A1 Spot test kit for explosives detection |
| 09/08/2006 | CA2561367A1 Protein crystal detecting device and protein crystal detecting method |
| 09/07/2006 | WO2005074641B1 Variant neuronal nicotinic alpha-7 receptor and methods of use |
| 09/07/2006 | WO2005034926A9 Non-invasive system for detecting skin cancer |
| 09/07/2006 | US20060200021 Electrically-conductive patterns for monitoring the filling of medical devices |
| 09/07/2006 | US20060200019 Bioavailability; biosensors; enzyme-based electrochemical sensors and cell transplantation devices |
| 09/07/2006 | US20060199978 Compounds having serotonin 5-ht17 receptor antagonist activity and muscarinic m4 receptor agonist activity and their use in the treatment of psychotic disorders |
| 09/07/2006 | US20060199833 Novel chemiluminescent compounds and their use |
| 09/07/2006 | US20060199781 Assays based on BTF3 activity |
| 09/07/2006 | US20060199770 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 09/07/2006 | US20060199769 Alpha-fetoprotein peptides and uses thereof |
| 09/07/2006 | US20060199767 Contacting cardiac muscle cells with a neuregulin protein to activate the MAP kinase pathway in cardiac muscle cells and induce remodeling of cardiac muscle cell sarcomeric and cytoskeleton structures or cell-cell adhesions |
| 09/07/2006 | US20060199281 Surfaces coated with target-induced fluorescent compounds for detection of target elements |
| 09/07/2006 | US20060199280 Quantification of proteins |
| 09/07/2006 | US20060199279 Methods for identifying post-translationally modified polypeptides |
| 09/07/2006 | US20060199278 Double-sided device for multiplex dipstick immunodiagnostic |
| 09/07/2006 | US20060199277 Devices and methods for analyte assays with built-in result reporting using recognizable symbols |
| 09/07/2006 | US20060199276 Device for multiple rapid detection and testing of diseases, disorders and immunity in human, animals and the environment |
| 09/07/2006 | US20060199270 unobtrusively determining water content within a fuel cell; fuel cell body including an ionomeric membrane, water and a fluorophore contained therein; used to predict the dynamic response of the fuel cell during startup, operating condition changes, and changes during many small perturbations |
| 09/07/2006 | US20060199269 Method for assessing pyrimidine metabolism |
| 09/07/2006 | US20060199268 Method for assessing arteriosclerosis and diabetic nephropathy |
| 09/07/2006 | US20060199247 Method for identifying modulators gene expression |
| 09/07/2006 | US20060199242 Stain compounds containing fluorophore and reducible quenching unit; for detection of bacterial cells, monitoring electron transport chain function of bacterial cells, monitoring oxidation state of non-biological systems, and assaying the effectiveness of antibacterial or antimicrobial agents; kits |
| 09/07/2006 | US20060199237 Clinical assay for monitoring of agmatine |
| 09/07/2006 | US20060199236 Immunoassay with extended dynamic range |
| 09/07/2006 | US20060199235 Compositions and method for accurate early pregnancy diagnosis |
| 09/07/2006 | US20060199234 Method of diagnosing wood decay and decay diagnostic agent |
| 09/07/2006 | US20060199233 miR-155 assay |
| 09/07/2006 | US20060199232 Use of protein PSE3 as a marker for colorectal cancer |
| 09/07/2006 | US20060199231 Detection of activation of endothelial cells as surrogate marker for angiogenesis |
| 09/07/2006 | US20060199230 Use of prostate specific antigen to predict drug response |
| 09/07/2006 | US20060199229 Methods for identification of modulators of OSGPR116 activity, and their use in the treatment of disease |
| 09/07/2006 | US20060199228 Peptides for treatment of autoimmune diseases |
| 09/07/2006 | US20060199227 pHuman T2R receptors for acetaminophen ranitidine, strychnine and denatomium and related assays for identifying human bitter taste modulators |
| 09/07/2006 | US20060199226 Functional bioluminescence energy resonance transfer (BRET) assay to screen, identify and characterize receptor tyrosine kinase ligands |
| 09/07/2006 | US20060199223 Chemiluminescent compounds and their use |
| 09/07/2006 | US20060199221 Correction for temperature dependence assays |
| 09/07/2006 | US20060199220 Protein arrays and uses thereof |
| 09/07/2006 | US20060199219 Method for screening anti-ligand libraries for identifying anti-ligands specific for differentially and infrequently expressed ligands |
| 09/07/2006 | US20060199218 Modulators of leukocyte activation, compositions and methods of use |
| 09/07/2006 | US20060199216 Programmable molecular barcodes |
| 09/07/2006 | US20060199215 Waste water inspecting agent and waste water inspecting apparatus using the same |
| 09/07/2006 | US20060199211 Fluorous-based microarrays |
| 09/07/2006 | US20060199209 Enhanced detection of biological and bioactive components by resonance Raman spectroscopy |
| 09/07/2006 | US20060199205 Reagent sets and gene signatures for renal tubule injury |
| 09/07/2006 | US20060199196 Compositions and methods for using radio frequency identifiers in biological sciences |
| 09/07/2006 | US20060199195 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 09/07/2006 | US20060199194 Methods of detection using immuno-Q-Amp technology |
| 09/07/2006 | US20060199179 Method for diagnosis of colorectal tumors |
| 09/07/2006 | US20060199175 Novel field testing method and device for detection of equine protozoal myeloencephalitis |
| 09/07/2006 | US20060199174 Screen for agents that modulate replication of hepatitis C virus; detect NS4B nucleotide binding motif, nucleotide hydrolyzing activity, or a nucleotide-dependent RNA binding activity of the polypeptide |
| 09/07/2006 | US20060199168 Cell recovery |
| 09/07/2006 | US20060198904 Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens |
| 09/07/2006 | US20060198855 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 09/07/2006 | US20060198845 Monoclonal antibody against human hepatoma and use thereof |
| 09/07/2006 | US20060198842 treating skeletal muscle atrophy with a corticotropin releasing factor 2 receptor (CRF2R) agonist such as Sauvagine, urocortin II or an antibody |
| 09/07/2006 | US20060198841 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 09/07/2006 | US20060198840 increased in vivo half-lives due to the presence of an immunoglobulin G (IgG) constant domain; pharmacokinetics; diagnosis or immunotherapy; antibody conjugates; palivizumab |
| 09/07/2006 | US20060198815 Pharmaceutical formulations for sustained release |
| 09/07/2006 | US20060198792 SBD from glucoamylase of fungi genus Rhizopus for use as a tag; a recombinant protein containing this sequence can be more easily purified and separated by contacting with an affinity matrix such as starch, to which it will bind |
| 09/07/2006 | US20060198791 Stimulation, inhibition or regulation of Wnt canonical signaling pathway; third YWTD repeat causes DKK1 mediated antagonism; G171V mutation disrupted interaction of LRP5 with Mesd |
| 09/07/2006 | US20060198788 Method of evaluating compound efficacious in treating obesity by using slc25a10 |
| 09/07/2006 | US20060198784 Methods of treatment using antibodies to Neutrokine-alpha |
| 09/07/2006 | US20060197960 Optoelectronic biochip |
| 09/07/2006 | US20060197955 Device for measuring immunochromatography test piece |